ASBPW / Aspire Biopharma Holdings, Inc. - Equity Warrant - Kepemilikan Institusional - Pembeli

Aspire Biopharma Holdings, Inc. - Equity Warrant

Kepemilikan Institusional dan Dana - Pembeli

Pemegang saham utama yang telah membuka posisi baru di Aspire Biopharma Holdings, Inc. - Equity Warrant meliputi Toronto Dominion Bank, Sculptor Capital LP, Nomura Holdings Inc, VR Advisory Services Ltd, Limestone Investment Advisors LP, Caas Capital Management Lp, Advisor Group Holdings, Inc., dan Investors Research Corp .

Halaman ini menunjukkan perubahan dalam struktur kepemilikan dengan mencantumkan lembaga, dana, dan pemegang saham utama yang telah meningkatkan kepemilikan mereka atau membuka posisi baru pada periode pelaporan terakhir. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium.

Tanggal File Sumber Investor Ketik Presyo ng Avg
(Silangan)
Saham Δ Saham
(%)
Dilaporkan
Nilai
($1000)
Nilai Δ
(%)
Alokasi Port
(%)
2025-08-18 13F/A Nomura Holdings Inc 150,000 7
2025-09-04 13F/A Advisor Group Holdings, Inc. 50 0
2025-08-14 13F Sculptor Capital LP 500,000 22
2025-08-14 13F Toronto Dominion Bank 516,845 23
2025-08-14 13F Limestone Investment Advisors LP 75,000 3
2025-08-12 13F Proequities, Inc. 0 0
2025-07-07 13F Investors Research Corp 10 0
2025-08-12 13F Highbridge Capital Management Llc 47 -54.46
2025-08-12 13F Jpmorgan Chase & Co 4 -33.33
2025-05-01 13F Caas Capital Management Lp 75,000 5
2025-08-13 13F Flow Traders U.s. Llc 14,491 2.11 0
2025-08-14 13F VR Advisory Services Ltd 99,692 4
2025-06-26 NP Voya Prime Rate Trust 4
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista